Early and sustained improvements in disease activity with filgotinib by prior advanced therapy in the real world: Interim data from the FILOSOPHY and PARROTFISH studies in patients with rheumatoid arthritis (RA)

Jyseleca (filgotinib) - Gilead

https://distribution-congress.eular.org/from.storage?image=15rRXWmdOAJ77zPlkD-rQvbAmhmcYfKP16eCOo7Aa1WdalmaclYUf458vT42f3yS0

Patrick Verschueren1, 2; Harald E. Vonkeman3, 4; Gerd R. Burmester5; Ana Urruticoechea-Arana6; Alessandra Oortwijn7; Thomas P.A. Debray8; Carole Van der Donckt9; Neil McKay10; Christian Roux11; Roberto F. Caporali12, 13

May 23, 2026